All Stories

  1. FAPI Tracer en Vogue: Evaluating [68Ga]Ga-DATA5m.SA.FAPi for Molecular Imaging of Pulmonary Fibrosis
  2. Fatty acid-binding protein 5 aggravates psoriasis and psoriasis-like disease through ferroptosis
  3. A Sex-Specific Anti-Inflammatory Role for p62 in Psoriasis-Like Disease
  4. Fecal Detection of Calprotectin Subunits Links Inflammatory Bowel Disease Activity With Chronicity of Intestinal Inflammation
  5. Fosl1 is a transcriptional effector of BRAFV600E-driven intestinal tumorigenesis
  6. Nutritional c‐Fos Induction Rewires Hepatic Metabolism and Can Promote Obesity‐Associated Hepatocellular Carcinoma
  7. Chronic skin and systemic inflammation modulated by S100A8 and S100A9 complexes
  8. A new effLuc/Kate dual reporter allele for tumor imaging in mice
  9. c-Jun and Fra-2 pair up to Myc-anistically drive HCC
  10. c-Jun and Fra-2 Pair Up to Myc-anistically Drive HCC    
  11. Dual therapeutic targeting of MYC and JUNB transcriptional programs for enhanced anti-myeloma activity
  12. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc (Author copy)  
  13. Molecular signalling pathway of liver cancer development decoded
  14. Metabolic rewiring controlled by c-Fos governs cartilage integrity in osteoarthritis
  15. Open Thy Lattice Osteoclast, Resorb me!
  16. Keratinocyte-derived S100A9 modulates neutrophil infiltration and affects psoriasis-like skin and joint disease
  17. An immune-sympathetic neuron communication axis guides adipose tissue browning in cancer-associated cachexia
  18. TPL-2 Inhibits IFN-β Expression via an ERK1/2-TCF-FOS Axis in TLR4-Stimulated Macrophages
  19. Targeting AP-1 transcription factors by CRISPR in the prostate
  20. NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1
  21. Calprotectin: from biomarker to biological function
  22. Sequestosome 1/p62 enhances chronic skin inflammation
  23. JunB is a key regulator of multiple myeloma bone marrow angiogenesis
  24. Psoriatic skin inflammation is promoted by c‐Jun/AP‐1‐dependent CCL2 and IL‐23 expression in dendritic cells
  25. In vivo CRISPR inactivation of Fos promotes prostate cancer progression by altering the associated AP-1 subunit Jun
  26. Pharmacologic Activation of LXR Alters the Expression Profile of Tumor-Associated Macrophages and the Abundance of Regulatory T Cells in the Tumor Microenvironment
  27. Wnt signaling and Loxl2 promote aggressive osteosarcoma
  28. Fra-2–expressing macrophages promote lung fibrosis
  29. EGFR is required for FOS‐dependent bone tumor development via RSK2/CREB signaling
  30. Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
  31. EGFR controls bone development by negatively regulating mTOR-signaling during osteoblast differentiation
  32. Transcriptional regulation by NR5A2 links differentiation and inflammation in the pancreas
  33. Fra-2 negatively regulates postnatal alveolar septation by modulating myofibroblast function
  34. Transcriptional regulation by NR5A2 couples cell differentiation and inflammation in the pancreas
  35. Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulation
  36. The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment
  37. Epidermal-specific deletion of CD44 reveals a function in keratinocytes in response to mechanical stress
  38. News and views on EMT Fra-1 controls EMT in mammary epithelial cells
  39. Osteogenic capillaries orchestrate growth plate-independent ossification of the malleus
  40. Characterization of Mouse Model-Derived Osteosarcoma (OS) Cells In Vitro and In Vivo
  41. Terminal epidermal differentiation is regulated by the interaction of Fra-2/AP-1 with Ezh2 and ERK1/2
  42. Loss of JUNB/AP-1 promotes invasive prostate cancer
  43. Inhibition of De Novo NAD + Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
  44. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression
  45. A FATal AP-1 dimer switch in hepatosteatosis
  46. Regulation of Steatohepatitis and PPARγ Signaling by Distinct AP-1 Dimers
  47. JUNB/AP-1 controls IFN-γ during inflammatory liver disease
  48. Activator protein 1 transcription factor fos-related antigen 1 (fra-1) is dispensable for murine liver fibrosis, but modulates xenobiotic metabolism
  49. Inflammation-mediated skin tumorigenesis induced by epidermal c-Fos
  50. Hepatitis C virus core+1/ARF protein decreases hepcidin transcription through an AP1 binding site
  51. Mouse models for liver cancer
  52. Osteoblast-specific expression of Fra-2/AP-1 controls Adiponectin/Osteocalcin expression and affects metabolism
  53. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin
  54. Differentiation-induced skin cancer suppression by FOS, p53, and TACE/ADAM17
  55. Pancreatic β-cells activate a JunB/ATF3-dependent survival pathway during inflammation
  56. Functions of Fos phosphorylation in bone homeostasis, cytokine response and tumourigenesis
  57. Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production
  58. TNFα shedding and epidermal inflammation are controlled by Jun proteins
  59. JunB Inhibits ER Stress and Apoptosis in Pancreatic Beta Cells
  60. Osteoclast size is controlled by Fra-2 through LIF/LIF-receptor signalling and hypoxia
  61. c-Jun Controls Histone Modifications, NF-κB Recruitment, and RNA Polymerase II Function To Activate the ccl2 Gene
  62. p38α: A Suppressor of Cell Proliferation and Tumorigenesis
  63. Dimer Composition and Promoter Context Contribute to Functional Cooperation between AP-1 and NFAT
  64. Targeting c-Jun and JunB proteins as potential anticancer cell therapy
  65. p38α suppresses normal and cancer cell proliferation by antagonizing the JNK–c-Jun pathway
  66. Role of heterodimerization of c-Fos and Fra1 proteins in osteoclast differentiation
  67. Fra-1 promotes growth and survival in RAS-transformed thyroid cells by controlling cyclin A transcription
  68. Essential role of RSK2 in c-Fos–dependent osteosarcoma development
  69. AP-1 dimers regulate transcription of the p14/p19ARF tumor suppressor gene
  70. Distinct functions of junD in cardiac hypertrophy and heart failure
  71. Fos and Jun Proteins Are Specifically Expressed During Differentiation of Human Keratinocytes
  72. Promoter Specificity and Biological Activity of Tethered AP-1 Dimers
  73. Functional cooperation between JunD and NF-κB in rat hepatocytes
  74. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression
  75. Stress-activated protein kinases are negatively regulated by cell density
  76. Induction of apoptosis by the transcription factor c-Jun
  77. Identification of a Novel 135-kDa Grb2-binding Protein in Osteoclasts